HW

Hugues Wallemacq

CEO EXO Biologics Group

Liège, Walloon Region

Investor
VC

Invests in

Locations:

Belgium

  • Min Investment:

    $100,000.00

  • Max Investment:

    $5,000,000.00

  • Target Investment:

    $1,500,000.00

Skills

Lifesciences
Molecular Biology
Biotechnology
Immunology
Cell Culture
Vaccines
Biochemistry
Cell Biology
ELISA
Western Blotting
PCR
Pharmaceutical Industry
In Vivo
Animal Models
Flow Cytometry
GLP
GCP
R
Validation
Développement clinique

Education

Lists including Hugues

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

Work Experience

EB
EXO Biologics

2021

  • Chief Executive Officer

    2022

  • Chief Operations Officer

    2021 - 2022

N
Noshaq

2020

  • Investment Manager

    2020

U
Unisensor

2016 - 2022

  • Board Member

    2020 - 2022

  • Head of Business Development

    2020 - 2021

  • Director Research and Development

    2016 - 2020

G
GSK

2010 - 2016

  • Director Clinical Immuno-Chemistry Assays

    2013 - 2016

  • Preclinical leader

    2010 - 2013

Ud
Université de Liège

2006 - 2010

  • PhD Immunology

    2006 - 2010

    PhD performed at GIGA I3 in the lab of Pr Fabrice Bureau (Molecular and cellular immunology).

French veterinarian clinics

2003 - 2006

  • Veterinarian

    2003 - 2006